Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Avex Inc. ( (JP:7860) ) is now available.
Avex Inc. will absorb its wholly owned subsidiary Avex Healthcare Empower LLC in a short-form merger effective April 1, 2026, dissolving the smaller unit without issuing new shares or paying consideration. The move, approved by the board on February 26, 2026, is aimed at consolidating management resources and improving organizational efficiency within the group after the healthcare subsidiary posted small-scale sales and negative net assets.
Because the deal qualifies as a simplified merger under Japan’s Companies Act, Avex will not convene a shareholder meeting, and all AHE members have already consented to the transaction. The reorganization is expected to streamline governance and reduce administrative overlap around the loss-making healthcare business, with limited direct financial impact given AHE’s modest size relative to the parent company.
The most recent analyst rating on (JP:7860) stock is a Hold with a Yen1215.00 price target. To see the full list of analyst forecasts on Avex Inc. stock, see the JP:7860 Stock Forecast page.
More about Avex Inc.
Avex Inc., listed on the TSE Prime Market, is a Japanese holding company overseeing the Avex Group, with operations spanning advertising, promotion, and event planning and production. Established in 1988 and headquartered in Tokyo’s Minato ward, the company acts as the group’s strategic hub while subsidiaries handle specialized business domains across its portfolio.
Average Trading Volume: 209,294
Technical Sentiment Signal: Sell
Current Market Cap: Yen54.14B
Find detailed analytics on 7860 stock on TipRanks’ Stock Analysis page.